1-1 of 1
Michael Richter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fedratinib in combination with CC-486, an oral hypomethylating agent, in patients with accelerated phase myelofibrosis: Results from the phase I/II famy trial

Free
Nadja Jaekel, Susann Schulze, Christina Zahn, Andreas Wienke, Michael Richter, Steffen Koschmieder, Martin Griesshammer, Katja Sockel, Regina Herbst, Claudia Wickenhauser, Haifa Kathrin Al-Ali
Journal: Blood
Blood (2025) 146 (Supplement 1): 3804.
https://doi.org/10.1182/blood-2025-3804
Published: 2025